semaglutide indication Oral Gets FDA Approval for CV Event Reduction in High-risk Diabetes Patients Ozempic® (semaglutide) GLP-1 RA for

This is how our gut bacteria may communicate with us

Important Note 5: SGLT2 Inhibitors

Evaluation: Body fat (DXA scanning) Lean mass Insulin sensitivity Energy expenditure What they found: The combination showed an additive effect on fat reduction vs monotherapy AOD-9604 partially protected lean mass during GLP-1-induced weight reduction Increased energy expenditure in combination (~3 % vs GLP-1 alone) No new safety signals Why it matters: It validates the concept of combination , the idea that AOD-9604 may not work on its own, but can add value in combination with incretin agonists

Because glutathione works from inside the body by regulating melanin and reducing oxidative stress, results appear naturally over time , not overnight